In-depth: New licenses could spark manufacture of COVID-19 pills in Africa

In-depth: New licenses could spark manufacture of COVID-19 pills in Africa

Pharmaceutical companies Merck and Pfizer recently announced early results from clinical trials showing that two new antiviral medicines are highly effective in reducing COVID-19 deaths and hospitalisation. The Medicines Patent Pool then announced licensing deals with both companies that will allow for generic versions of the two drugs to be produced. Catherine Tomlinson unpacks the licenses and asks whether generic versions of these pills might now be made in Africa.

Read More

Health and Unrest: Counting the cost and getting people their medicines

Health and Unrest: Counting the cost and getting people their medicines

As the country is still calculating the tally of the vaccine stock and medicines stolen in last week’s unrest in KwaZulu-Natal and Gauteng, there is still a lot of uncertainty about plans to restore medicine security.

Read More

COVID-19: Eight common questions answered about the Delta variant

COVID-19: Eight common questions answered about the Delta variant

The new and more contagious Delta variant has now surpassed the Beta variant to become the dominant SARS-CoV-2 variant in South Africa. Laura Lopez Gonzalez pulled together answers to eight common questions asked about this new variant.

Read More

COVID-19: Will vaccinated people in South Africa need booster shots?

COVID-19: Will vaccinated people in South Africa need booster shots?

The two vaccines used in South Africa’s vaccination programme, those from Johnson & Johnson and Pfizer/BioNTech, have both been shown to be highly effective against COVID-19, particularly in preventing hospitalisation and death. But protection may wane over time and new variants may or may not render these vaccines less effective. Adele Baleta unpacks what we do and do not know about the potential need for booster shots and surveys some of the studies that will help fill the gaps.

Read More

High hopes for deal to unlock local COVID-19 vaccine manufacturing

High hopes for deal to unlock local COVID-19 vaccine manufacturing

On Monday President Cyril Ramaphosa announced that South Africa will host the first World Health Organization-backed COVID-19 mRNA vaccine Technology Transfer Hub – an initiative designed to get the production of mRNA vaccines off the ground in Africa. Parties involved in the hub expect to hear as early as next week whether pharmaceutical companies with mRNA COVID-vaccines for COVID-19 on the market – Moderna and Pfizer/BioNTech – will share their know-how with the hub. Chris Bateman reports for Spotlight.

Read More

Hits and misses of the national vaccine rollout – experts weigh in

Hits and misses of the national vaccine rollout – experts weigh in

Government has been criticised for the slow pace of the country’s vaccine rollout which started on 17 May 2021. Elri Voigt spoke to experts to hear what is being done right in this vaccine rollout and where improvements are needed.

Read More

COVID-19: Numbers escalating in Free State schools

COVID-19: Numbers escalating in Free State schools

While it is uncertain when teachers in the Free State will receive vaccinations during this third wave, the number of COVID-19 infections and deaths in the province’s schools continues to increase. Refilwe Mochoari reports.

Read More

Trial of potentially variant-proof vaccine ongoing in Western Cape

Trial of potentially variant-proof vaccine ongoing in Western Cape

An experimental COVID-19 vaccine currently in Phase I trials being run by the University of Cape Town has a unique design that might allow it to offer better protection against current and future variants of the SARS-CoV-2 virus. Elri Voigt provides an update on the trial and unpacks the science behind this vaccine candidate.

Read More